FOXL2 Antibody

There are 2 forms of the blepharophimosis/ptosis/epicanthus inversus syndrome. In one form, called type I, eyelid abnormalities are associated with ovarian failure. In the second type, called type II, only the eyelid defects are found. Both types map to 3q23. Crisponi et al. (2001) refined the physical mapping of the BPES critical region and positionally cloned a novel, putative winged helix/forkhead transcription factor gene, FOXL2, in which they found mutations to produce truncated proteins in type I families and larger proteins in type II. Consistent with an involvement in those tissues, FOXL2 was selectively expressed in the mesenchyme of developing mouse eyelids and in adult ovarian follicles; in adult humans, it appeared predominantly in the ovary.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Mouse.

We have publications tested in 1 application: FLOW.

Showing Publication 1 - 1 of 1.

Publication using NBP2-22473	Applications	Species
Pierini S, Tanyi JL, Simpkins F et al. Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target JCI Insight 2020-08-20 [PMID: 32814714] (FLOW, Mouse)	FLOW	Mouse

Array NBP2-22473

• FOXL2 Antibodies
• FOXL2 Lysate
• FOXL2 Proteins